Extensive experience in business development with AstraZeneca and GSKMILAN, Italy and NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) -- Genenta…
Upcoming PDUFA date of May 24, 2022 for VP-102 NDA for the treatment of molluscum First patient dosed in Phase…
BASEL, Switzerland, May 09, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel…
CALGARY, Alberta, May 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix", or "the Company") (TSX:RVX), in partnership with EVERSANA™, today…
– Cash runway extended into 2024 – – Strengthened financial position with achievement of $30 million milestone from GlaxoSmithKline and…
MoonLake Immunotherapeutics announces the publication of new long-term disease control data from a Phase 2b Psoriasis trial of the Nanobody®sonelokimab…
FDA review of NDA for FT218 continues; launch readiness preparations on-track to support potential commercial launchPresented interim results from ongoing…
PHILADELPHIA, May 09, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing…
– Initial data from Phase 1b trial of FTX-6058 in sickle cell disease to be presented at the EHA 2022…
Toronto, Ontario--(Newsfile Corp. - May 9, 2022) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red…